| Authors: |
Ohkuma R; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Showa Medical University Comprehensive Cancer Information Center, Showa Medical University, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Onishi N; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Watanabe M; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Jin J; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Ariizumi H; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Shimokawa M; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Ikeda G; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Ishiguro T; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Suzuki R; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Tsurui T; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Kubota Y; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Yoshimura K; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsunoda T; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.; Showa Medical University Comprehensive Cancer Information Center, Showa Medical University, Tokyo, Japan., Horiike A; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Wada S; Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan. st-wada@med.showa-u.ac.jp.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan. st-wada@med.showa-u.ac.jp.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan. st-wada@med.showa-u.ac.jp.; Department of Pharmacology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan. st-wada@med.showa-u.ac.jp. |
